Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 57

Sort by

Sort Order Select

Journal Articles

Autologous Hematopoietic Stem Cell Transplantation Versus Intravenous Pulse Therapy Cyclophosphamide for Severe or Rapidly Progressive Systemic Sclerosis, the Astis Trial

Blood (2012) 120 (21): 964.

https://doi.org/10.1182/blood.V120.21.964.964

Published: 2012

Journal Articles

Hematopoietic Cell Mobilization for Gene Therapy of Adult Patients with Severe Beta-Thalassemia: The Challenge of Splenectomy and the Role of Plerixafor

Evangelia Yannaki, MD, Thalia Papayannopoulou, Erica Jonlin, PhD, Fani Zervou, Garyfalia Karponi, Angeliki Xagorari, PhD, Pamela S. Becker, MD, PhD, Nikoleta Psatha, Ioannis Batsis, MD, Panayotis Kaloyannidis, MD, Varvara Tahynopoulou, Varnavas Constantinou, Asimenia Bouinta, Konstantia Kotta, Aglaia Athanassiadou, PhD, Achilles Anagnostopoulos, Athanasios Fassas, MD, George Stamatoyannopoulos, MD, DSci

Blood (2011) 118 (21): 166.

https://doi.org/10.1182/blood.V118.21.166.166

Published: 2011

Journal Articles

Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party

Blood (2011) 118 (6): 1693–1698.

https://doi.org/10.1182/blood-2011-02-336156

Published: 2011

Journal Articles

Incidence and Risk Factors for Secondary Autoimmune Diseases (AD) After Hematopoietic Stem Cell Transplantation (HSCT) for a Severe Autoimmune Disease-A Retrospective EBMT WP AD Study

Blood (2010) 116 (21): 2322.

https://doi.org/10.1182/blood.V116.21.2322.2322

Published: 2010

Journal Articles

OUTCOME of Allogeneic Hematopoietic CELL TRANSPLANTATION for AML: A Single CENTER Retrospective ANALYSIS.

Ioanna Sakellari, Chrisa Apostolou, Despina Mallouri, Anastasia Athanasiadou, Ioannis Batsis, Christos Smias, Evangelia Yannaki, Chrisavgi Lalayanni, Antonia Syrigou, Niki Stavrogianni, Chrisanthi Vadikolia, Riant Saloum, Athanasios Fassas, Achilles Anagnostopoulos

Blood (2010) 116 (21): 4567.

https://doi.org/10.1182/blood.V116.21.4567.4567

Published: 2010

Journal Articles

Successful Hematopoietic STEM CELL Mobilization with GRANULOCYTE Colony Stimulating FACTOR PLUS Plerixafor (MOZOBIL, AMD3100) IN POOR Mobilizers: A Single CENTER STUDY

Despina Mallouri, Ioanna Sakellari, Chrisa Apostolou, Panayotis Baliakas, Apostolia Papalexandri, Aliki Tsobanakou, Ioannis Batsis, Evangelia Yannaki, Christos Smias, Damianos Sotiropoulos, Athanasios Fassas, Achilles Anagnostopoulos

Blood (2010) 116 (21): 4444.

https://doi.org/10.1182/blood.V116.21.4444.4444

Published: 2010

Journal Articles

Intravenous Busulphan in Combination with ETOPOSIDE and MELPHALAN Used as Conditioning Regimen for Autologous Hematopoietic Cell Transplantation in Lymphomas: Evaluation of Toxicity and Efficacy

Despina Mallouri, Ioanna Sakellari, Ioannis Batsis, Varnavas Konstantinou, Panayotis Baliakas, Athanasios Antoniou, Chrisa Apostolou, Achilles Anagnostopoulos, Athanasios Fassas

Blood (2010) 116 (21): 1324.

https://doi.org/10.1182/blood.V116.21.1324.1324

Published: 2010

Journal Articles

The Combination of AMD3100 + G-CSF Restores the Ineffective Hematopoietic Stem Cell Mobilization with G-CSF Alone in a Thalassemic Mouse Model.

Evangelia Yannaki, MD, Nikoleta Psatha, PhD, student, Maria Demertzi, BS, Evangelia Athanasiou, MD, Eleni Sgouramali, Student, Dimitris Bougiouklis, BS, Minas Arsenakis, Prof, Achilles Anagnostopoulos, MD, Athanasios Fassas, MD

Blood (2009) 114 (22): 3234.

https://doi.org/10.1182/blood.V114.22.3234.3234

Published: 2009

Journal Articles

Limitations of G-CSF Mobilization in Splenectomized Patients with Beta-Thalassemia Major: Implications for Thalassemia Gene Therapy.

Evangelia Yannaki, MD, Thalia Papayannopoulou, MD, Erica Jonlin, PhD, Ioannis Batsis, MD, Pamela S. Becker, MD, PhD, Fani Zervou, BS, Angeliki Xagorari, PhD, Garyfalia Karponi, BS, Varvara Tahynopoulou, BS, Panayotis Kaloyannidis, MD, Varnavas Constantinou, MD, Achilles Anagnostopoulos, MD, Athanasios Fassas, MD, George Stamatoyannopoulos, MD, DSci

Blood (2009) 114 (22): 2150.

https://doi.org/10.1182/blood.V114.22.2150.2150

Published: 2009

Journal Articles

Autologous Hematopoietic Stem Cell Transplantation (HSCT) for Autoimmune Diseases: 10 Years Experience from the European Group for Blood and Marrow Transplantation (EBMT) Working Party on Autoimmune Diseases

Dominique Farge, Myriam Labopin, Alan Tyndall, Athanasios Fassas, Gian Luigi Mancardi, Jaap Van Laar, Jian Ouyang, Tomas Kozak, John Moore, Ina Kötter, Virginie Chesnel, Alberto Marmont, Alois Gratwohl, MD, Riccardo Saccardi

Blood (2008) 112 (11): 164.

https://doi.org/10.1182/blood.V112.11.164.164

Published: 2008

Journal Articles

Early and Effective Immune-Recovery by Gene-Engineered Lymphocytes after Haploidentical Transplantation for Leukemia Abate Late Transplant Mortality

Blood (2008) 112 (11): 353.

https://doi.org/10.1182/blood.V112.11.353.353

Published: 2008

Journal Articles

Dose and Timing Limitations in the Use of Bone Marrow-Derived Mesenchymal Stem Cells for the Treatment of Experimental Arthritis.

Evangelia Yannaki, MD, Anastasia Papadopoulou, PhD student, Minas Yiangou, PhD, Evangelia Athanasiou, MD, Argyrw Paraskeva, BS, Ioannis Batsis, MD, Eleftheria Tsolaki, PhD student, Angeliki Xagorari, PhD, Achilles Anagnostopoulos, MD, Athanasios Fassas, MD

Blood (2008) 112 (11): 2326.

https://doi.org/10.1182/blood.V112.11.2326.2326

Published: 2008

Journal Articles

Rheumatoid Arthritis as a New Disease-Target for Bortezomib.

Evangelia Yannaki, MD, Anastasia Papadopoulou, PhD student, Argyrw Paraskeva, BS, Panayotis Kaloyannidis, MD, Evangelia Athanasiou, MD, Dimitris Bougiouklis, BS, Panayotis Palladas, MD, Minas Yiangou, PhD, Athanasios Fassas, MD, Achilles Anagnostopoulos

Blood (2008) 112 (11): 1543.

https://doi.org/10.1182/blood.V112.11.1543.1543

Published: 2008

Journal Articles

Intravenous Busulfan-Based Conditioning Prior to Allogeneic Stem Cell Transplantation in Adults Patients with AML - An ALWP-EBMT Survey.

Arnon Nagler, MD, Myriam Labopin, MD, Avichai Shimoni, MD, Donald Bunjes, MD, Pedro Pimentel, MD, Gerard Socie, MD, Karim Boudjedir, MD, Axel R. Zander, MD, A. Torres Gomez, MD, Michele Baccarini, MD, Hakan Goker, MD, Athanasios Fassas, MD, Chantal Kenzey, Benedicte Samey, Zouabi Hamadi, MD, Vanderson Rocha, MD

Blood (2007) 110 (11): 1995.

https://doi.org/10.1182/blood.V110.11.1995.1995

Published: 2007

Journal Articles

Over 20% of Patients with Chronic Lymphocytic Leukemia Carry Stereotyped Receptors: Pathogenetic Implications and Clinical Correlations.

Blood (2006) 108 (11): 26.

https://doi.org/10.1182/blood.V108.11.26.26

Published: 2006

Journal Articles

Outcome of Patients with Primary Refractory Acute Myeloid Leukemia (AML) Undergoing Myeloablative Allogeneic Stem-Cell Transplantation (alloSCT) from HLA-Identical Sibling: Favorable Outcome in a Subset of Patients.

Jordi Esteve, MD, Myriam Labopin, MD, Gerhard Ehninger, MD, Athanasios Fassas, MD, Jurgen Finke, MD, Miguel A. Sanz, MD, Paolo Alessandrino, MD, Axel Arthur Fauser, MD, Vanderson Rocha, MD

Blood (2006) 108 (11): 3022.

https://doi.org/10.1182/blood.V108.11.3022.3022

Published: 2006

Journal Articles

Immunized Against Hepatitis B Virus Allografted Recipients Are at High Risk for Gradual Surface Antibody (HbsAb) Disappearance Post Transplant, Regardless of Adoptive Immunity Transfer: A Study of 82 Allografted Long Term Survivors.

Panayotis Kaloyannidis, MD, Evangelia Yannaki, MD, Ioannis Batsis, MD, Despoina Adamidou, MD, Demetrios Bartzoudis, MD, Maria Papathanasiou, MD, Despoina Mallouri, MD, Ioanna Sakellari, MD, Athanasios Fassas, MD, Achilles Anagnostopoulos, MD

Blood (2006) 108 (11): 2862.

https://doi.org/10.1182/blood.V108.11.2862.2862

Published: 2006

Journal Articles

Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations

Blood (2006) 109 (1): 259–270.

https://doi.org/10.1182/blood-2006-03-012948

Published: 2006

Includes: Supplemental data

Journal Articles

Total therapy 2 without thalidomide in comparison with total therapy 1: role of intensified induction and posttransplantation consolidation therapies

Bart Barlogie, Guido Tricot, Erik Rasmussen, Elias Anaissie, Frits van Rhee, Maurizio Zangari, Athanasios Fassas, Klaus Hollmig, Mauricio Pineda-Roman, John Shaughnessy, Joshua Epstein, John Crowley

Blood (2006) 107 (7): 2633–2638.

https://doi.org/10.1182/blood-2005-10-4084

Published: 2006

Journal Articles

Evidence for Differential Regulation of Transferrin Receptor 1 in Normal vs. Malignant B Cells.

Ioanna Chiotoglou, Tatjana Smilevska, Kostas Stamatopoulos, Maria Samara, Sophia Likousi, Chrysoula Belessi, Nikolaos Laoutaris, Athanasios Fassas, Nikolaos Stathakis, Panagoula Kollia

Blood (2005) 106 (11): 3722.

https://doi.org/10.1182/blood.V106.11.3722.3722

Published: 2005

NARROW

Autologous Hematopoietic Stem Cell Transplantation Versus Intravenous Pulse Therapy Cyclophosphamide for Severe or Rapidly Progressive Systemic Sclerosis, the Astis Trial

Hematopoietic Cell Mobilization for Gene Therapy of Adult Patients with Severe Beta-Thalassemia: The Challenge of Splenectomy and the Role of Plerixafor

Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party

Incidence and Risk Factors for Secondary Autoimmune Diseases (AD) After Hematopoietic Stem Cell Transplantation (HSCT) for a Severe Autoimmune Disease-A Retrospective EBMT WP AD Study

OUTCOME of Allogeneic Hematopoietic CELL TRANSPLANTATION for AML: A Single CENTER Retrospective ANALYSIS.

Successful Hematopoietic STEM CELL Mobilization with GRANULOCYTE Colony Stimulating FACTOR PLUS Plerixafor (MOZOBIL, AMD3100) IN POOR Mobilizers: A Single CENTER STUDY

Intravenous Busulphan in Combination with ETOPOSIDE and MELPHALAN Used as Conditioning Regimen for Autologous Hematopoietic Cell Transplantation in Lymphomas: Evaluation of Toxicity and Efficacy

The Combination of AMD3100 + G-CSF Restores the Ineffective Hematopoietic Stem Cell Mobilization with G-CSF Alone in a Thalassemic Mouse Model.

Limitations of G-CSF Mobilization in Splenectomized Patients with Beta-Thalassemia Major: Implications for Thalassemia Gene Therapy.

Autologous Hematopoietic Stem Cell Transplantation (HSCT) for Autoimmune Diseases: 10 Years Experience from the European Group for Blood and Marrow Transplantation (EBMT) Working Party on Autoimmune Diseases

Early and Effective Immune-Recovery by Gene-Engineered Lymphocytes after Haploidentical Transplantation for Leukemia Abate Late Transplant Mortality

Dose and Timing Limitations in the Use of Bone Marrow-Derived Mesenchymal Stem Cells for the Treatment of Experimental Arthritis.

Rheumatoid Arthritis as a New Disease-Target for Bortezomib.

Intravenous Busulfan-Based Conditioning Prior to Allogeneic Stem Cell Transplantation in Adults Patients with AML - An ALWP-EBMT Survey.

Over 20% of Patients with Chronic Lymphocytic Leukemia Carry Stereotyped Receptors: Pathogenetic Implications and Clinical Correlations.

Outcome of Patients with Primary Refractory Acute Myeloid Leukemia (AML) Undergoing Myeloablative Allogeneic Stem-Cell Transplantation (alloSCT) from HLA-Identical Sibling: Favorable Outcome in a Subset of Patients.

Immunized Against Hepatitis B Virus Allografted Recipients Are at High Risk for Gradual Surface Antibody (HbsAb) Disappearance Post Transplant, Regardless of Adoptive Immunity Transfer: A Study of 82 Allografted Long Term Survivors.

Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations

Total therapy 2 without thalidomide in comparison with total therapy 1: role of intensified induction and posttransplantation consolidation therapies

Evidence for Differential Regulation of Transferrin Receptor 1 in Normal vs. Malignant B Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only